Pfizer has started clinical trials on an Omicron-tailored version of its COVID-19 vaccine. US health officials believe the variant will be the dominant strain in the community for some time, and a targeted vaccine will be beneficial as a booster.
Virologist with the University of Warwick, Lawrence Young, says this vaccine will be very different from the original.
Subscribe: [ Ссылка ]
ABC News provides around the clock coverage of news events as they break in Australia and abroad, including the latest coronavirus pandemic updates. It's news when you want it, from Australia's most trusted news organisation.
For more from ABC News, click here: [ Ссылка ]
Watch more ABC News content ad-free on iview: [ Ссылка ]
Go deeper on our ABC News In-depth channel: [ Ссылка ]
Like ABC News on Facebook: [ Ссылка ]
Follow ABC News on Instagram: [ Ссылка ]
Follow ABC News on Twitter: [ Ссылка ]
Note: In most cases, our captions are auto-generated.
#ABCNews #ABCNewsAustralia
